Growth Metrics

cbdMD (YCBD) EPS (Basic) (2016 - 2025)

cbdMD's EPS (Basic) history spans 10 years, with the latest figure at -$0.04 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 97.69% year-over-year to -$0.04; the TTM value through Dec 2025 reached -$3.88, up 82.5%, while the annual FY2022 figure was -$1.24, 163.83% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.04 at cbdMD, up from -$0.21 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.17 in Q2 2023 and bottomed at -$10.84 in Q1 2024.
  • The 5-year median for EPS (Basic) is -$0.35 (2021), against an average of -$1.77.
  • The largest annual shift saw EPS (Basic) crashed 1933.33% in 2022 before it surged 312.73% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.35 in 2021, then plummeted by 957.14% to -$3.7 in 2022, then surged by 81.89% to -$0.67 in 2023, then tumbled by 158.21% to -$1.73 in 2024, then soared by 97.69% to -$0.04 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's EPS (Basic) are -$0.04 (Q4 2025), -$0.21 (Q2 2025), and -$1.9 (Q1 2025).